Adlai Nortye Ltd. ADR (ANL) Ownership
ANL ownership summary
as of October 18, 2026- Institutions
- 41.3% of shares outstanding
- Insiders
- 0.94% of shares outstanding
- Shares outstanding
- 58.7M
- Float
- 49.6M shares available to trade
- Short interest
- 7.56% 4.4M shares short
- Days to cover
- 28.04 short interest down 0.5% vs prior month
- Institutions 41.33%
- Insiders 0.94%
- Other investors 57.73%
ANL top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Cormorant Asset Management, LLC | 6.18% | 4.0M | $43.9M | +1.1M (+37.3%) | June 30, 2026 |
| 2 | VR Adviser, LLC | 4.99% | 3.2M | $35.4M | — | June 30, 2026 |
| 3 | Balyasny Asset Management LLC | 4.75% | 3.1M | $33.8M | +2.2M (+248.8%) | June 30, 2026 |
| 4 | Point72 Asset Management, L.P. | 3.32% | 2.1M | $23.6M | +2.1M (0.0%) | June 30, 2026 |
| 5 | MPM Oncology Impact Management LP | 3.01% | 1.9M | $21.4M | +1.9M (0.0%) | June 30, 2026 |
| 6 | Perceptive Advisors LLC | 2.78% | 1.8M | $19.8M | +1.8M (0.0%) | June 30, 2026 |
| 7 | Casdin Capital, LLC | 1.94% | 1.2M | $13.8M | +711,539 (+132.1%) | June 30, 2026 |
| 8 | ADAR1 Capital Management LLC | 1.58% | 1.0M | $11.2M | +899,896 (+763.2%) | June 30, 2026 |
| 9 | Octagon Capital Advisors LP | 1.45% | 935K | $10.3M | +934,716 (0.0%) | June 30, 2026 |
| 10 | Millennium Management LLC | 1.25% | 808K | $8.9M | +126,057 (+18.5%) | June 30, 2026 |
| 11 | BRAIDWELL LP | 1.23% | 795K | $8.8M | +795,214 (0.0%) | June 30, 2026 |
| 12 | Squadron Capital Management LLC | 1.19% | 765K | $8.4M | −500,355 (−39.5%) | June 30, 2026 |
| 13 | Eventide Asset Management, LLC | 1.12% | 719K | $7.9M | +718,747 (0.0%) | June 30, 2026 |
| 14 | SUPERSTRING CAPITAL MANAGEMENT LP | 0.86% | 553K | $6.1M | +137,649 (+33.2%) | June 30, 2026 |
| 15 | Adage Capital Partners Gp LLC | 0.84% | 538K | $5.9M | — | June 30, 2026 |
| 16 | Woodline Partners LP | 0.71% | 456K | $5.0M | +246,474 (+117.8%) | June 30, 2026 |
| 17 | Soleus Capital Management, L.P. | 0.63% | 406K | $4.5M | +405,523 (0.0%) | June 30, 2026 |
| 18 | Freestone Grove Partners LP | 0.62% | 397K | $4.4M | +397,446 (0.0%) | June 30, 2026 |
| 19 | BOONE CAPITAL MANAGEMENT LLC | 0.40% | 258K | $2.9M | +258,390 (0.0%) | June 30, 2026 |
| 20 | Dafna Capital Management LLC | 0.37% | 240K | $2.6M | +239,553 (0.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 17 holders added 15.0M shares and 1 cut 500K.
ANL top mutual fund and ETF holders
8 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Eventide Healthcare & Life Sciences I | 1.12% | 719K | $7.9M | +718,747 (0.0%) | June 30, 2026 |
| 2 | Tema Oncology ETF | 0.12% | 75K | $830,371 | — | September 30, 2026 |
| 3 | Virtus LifeSci Biotech Clinical Trls ETF | 0.05% | 31K | $339,161 | — | September 30, 2026 |
| 4 | State Street® SPDR® S&P® EM Sm Cp ETF | 0.04% | 29K | $319,870 | — | September 30, 2026 |
| 5 | Fidelity Nasdaq Composite Index | 0.03% | 17K | $187,731 | — | August 31, 2026 |
| 6 | Telescope Biotech Fund A FIL | 0.01% | 8,951 | $98,730 | — | September 30, 2026 |
| 7 | State Street® SPDR® S&P® China ETF | 0.01% | 7,200 | $79,416 | — | September 30, 2026 |
| 8 | ProFunds UltraChina Inv | <0.01% | 1,156 | $12,751 | +1,156 (0.0%) | July 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
ANL shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns ANL
Institutional investors own 41.3% of Adlai Nortye Ltd. ADR's shares and insiders 0.94%. The largest holder is Cormorant Asset Management, LLC with 6.18% of the shares (4.0M), as of June 30, 2026. Among the top 20 institutions, 17 added shares and 1 reduced their stake in the latest filings. Short interest is 7.56% of the float, or 28.04 days of average trading volume. The share count rose 1,400.0% since 2021.
Related: ANL analyst forecast, ANL key metrics. See the ANL stock overview for the latest quote and news.
ANL ownership FAQ
Who owns the most Adlai Nortye Ltd. ADR stock?
The largest shareholders of Adlai Nortye Ltd. ADR are Cormorant Asset Management, LLC (6.18%), VR Adviser, LLC (4.99%), Balyasny Asset Management LLC (4.75%), Point72 Asset Management, L.P. (3.32%), MPM Oncology Impact Management LP (3.01%).
What percentage of Adlai Nortye Ltd. ADR is owned by institutions?
Institutions hold 41.3% of Adlai Nortye Ltd. ADR's shares outstanding; insiders hold 0.94%.
Which funds own Adlai Nortye Ltd. ADR?
The largest fund holders of Adlai Nortye Ltd. ADR are Eventide Healthcare & Life Sciences I (1.12%), Tema Oncology ETF (0.12%), Virtus LifeSci Biotech Clinical Trls ETF (0.05%), State Street® SPDR® S&P® EM Sm Cp ETF (0.04%), Fidelity Nasdaq Composite Index (0.03%).
What is Adlai Nortye Ltd. ADR's short interest?
4.4M shares of Adlai Nortye Ltd. ADR were sold short, 7.56% of the float; at the average daily volume it would take 28.04 days to cover.
How many shares of Adlai Nortye Ltd. ADR are outstanding?
Adlai Nortye Ltd. ADR has 58.7M shares outstanding, of which 49.6M are in the public float.